Clinical Trials Directory

Trials / Completed

CompletedNCT02431377

Acceptability and GI Tolerance of an Alpha-lactalbumin-enriched Formula

Acceptability and GI Tolerance of an Alpha-lactalbumin-enriched Formula: An Uncontrolled, Open-label, Descriptive Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
21 Days – 35 Days
Healthy volunteers
Accepted

Summary

A single center, non-controlled trial to document the gastrointestinal (GI) tolerability of the study formula (SF), containing a whey protein concentrate enriched with alpha-lactalbumin (WPC alpha-lac) fed for 6 weeks to healthy, term infants.

Detailed description

The purpose of this study is to examine the tolerable and acceptability of an infant formula with with a Whey protein concentrate containing alpha-lactalbumin as measure by GI tolerance, and eating behaviors.

Conditions

Interventions

TypeNameDescription
OTHERS-26 GoldA commercial whey protein dominant, first age formula, containing whey protein concentrate with alpha-lactalbumin

Timeline

Start date
2015-04-01
Primary completion
2015-09-01
Completion
2015-10-01
First posted
2015-05-01
Last updated
2015-11-03

Locations

1 site across 1 country: Philippines

Source: ClinicalTrials.gov record NCT02431377. Inclusion in this directory is not an endorsement.

Acceptability and GI Tolerance of an Alpha-lactalbumin-enriched Formula (NCT02431377) · Clinical Trials Directory